Putting new disease-modifying antirheumatic drugs into perspective

被引:0
|
作者
Saseen, Joseph J. [1 ,2 ]
机构
[1] Univ Colorado, Hlth Sci Ctr, Dept Clin Pharm, FCCP,BCPS, Denver, CO 80202 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Family Med, Denver, CO 80202 USA
来源
PHARMACOTHERAPY | 2007年 / 27卷 / 12期
关键词
rheumatoid arthritis; disease-modifying antirheumatic drugs; DMARD; abatacept; rituximab;
D O I
10.1592/phco.27.12.1609
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:1609 / 1610
页数:2
相关论文
共 50 条
  • [1] Disease-modifying antirheumatic drugs
    Lambert, David G.
    ANAESTHESIA AND INTENSIVE CARE MEDICINE, 2012, 13 (03) : 128 - 130
  • [2] Disease-modifying antirheumatic drugs
    Lambert, David G.
    ANAESTHESIA AND INTENSIVE CARE MEDICINE, 2009, 10 (01) : 35 - 37
  • [3] Disease-Modifying Antirheumatic Drugs
    Brasington, Richard
    JOURNAL OF HAND SURGERY-AMERICAN VOLUME, 2009, 34A (02): : 347 - 348
  • [4] Proposal for a new nomenclature of disease-modifying antirheumatic drugs
    Smolen, Josef S.
    van der Heijde, Desiree
    Machold, Klaus P.
    Aletaha, Daniel
    Landewe, Robert
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (01) : 3 - 5
  • [5] Vaccines and Disease-Modifying Antirheumatic Drugs Practical Implications for the Rheumatologist
    Friedman, Marcia A.
    Winthrop, Kevin L.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2017, 43 (01) : 1 - +
  • [6] IGURATIMOD: A NEW DISEASE-MODIFYING ANTIRHEUMATIC DRUG
    Mucke, H. A. M.
    DRUGS OF TODAY, 2012, 48 (09) : 577 - 586
  • [7] Disease-modifying antirheumatic drugs and organising pneumonia
    Faisal, Mohamed
    Roslan, Asyraf
    Abeed, Nik Nuratiqah Nik
    Ban Yu-Lin, Andrea
    BMJ CASE REPORTS, 2021, 14 (01)
  • [8] Conventional disease-modifying antirheumatic drugs to treat rheumatoid arthritis
    Rath, T.
    Sander, O.
    Rubbert, A.
    DRUG DEVELOPMENT RESEARCH, 2011, 72 (08) : 657 - 663
  • [9] Perinatal Use and Discontinuation of Disease-Modifying Antirheumatic Drugs
    Rebic, Nevena
    De Vera, Mary A.
    Gupta, Amit
    Amiri, Neda
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2024, 30 (05) : 188 - 192
  • [10] A Clinical and Economic Review of Disease-Modifying Antirheumatic Drugs
    Sherine E. Gabriel
    Douglas Coyle
    Larry W. Moreland
    PharmacoEconomics, 2001, 19 : 715 - 728